Mahkam Zanganeh - 11 Sep 2024 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Co-Chief Executive Officer, Director
Signature
/s/ Mahkam Zanganeh
Issuer symbol
SMMT
Transactions as of
11 Sep 2024
Net transactions value
+$999,980
Form type
4
Filing time
13 Sep 2024, 19:29:45 UTC
Previous filing
23 Aug 2024
Next filing
03 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Award $999,980 +44,052 +0.18% $22.70 24,967,852 11 Sep 2024 By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee F1, F2
holding SMMT Common Stock 9,884,095 11 Sep 2024 By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee. F2
holding SMMT Common Stock 50,000 11 Sep 2024 Immediate family member F2
holding SMMT Common Stock 520,814 11 Sep 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee, at a purchase price of $22.70 per share. The transaction closed on September 13, 2024.
F2 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.